之江生物: 之江生物：第五届监事会第十三次会议决议公告

Meeting Overview - The fifth meeting of the supervisory board of Shanghai Zhijiang Biological Technology Co., Ltd. was held on August 27, 2025, with all three supervisors present, confirming the legality and validity of the meeting [1] Financial Reporting - The supervisory board approved the 2025 semi-annual report, stating that it accurately reflects the company's financial status and operational results [1] Fund Management - The supervisory board confirmed that the company manages and uses raised funds in compliance with relevant regulations, ensuring no harm to the interests of the company and shareholders, especially minority shareholders [2] - The special report on the storage and use of raised funds for the first half of 2025 was deemed truthful, accurate, and complete [2] Project Adjustments - The supervisory board agreed to change certain fundraising projects, which aligns with industry conditions and the company's strategic development, enhancing the efficiency of fund usage without adversely affecting normal operations [2][3] Governance Changes - The supervisory board decided to abolish the supervisory board, transferring its powers to the audit committee of the board of directors, with corresponding amendments to the company's articles of association [3] - The supervisory board approved the temporary use of idle raised funds for cash management, not exceeding 60 million RMB, to improve fund efficiency and generate investment returns [3]